whether to treat ALL patients with type 2 diabetes with an ACE inhibitor to prevent nephropathy

January 2000

Experts are now debating whether to treat ALL patients with type 2 diabetes with an ACE inhibitor to prevent nephropathy.

The current recommendation is to treat only patients who develop microalbuminuria...an early sign of kidney damage.

But now some experts advocate earlier treatment...to prevent kidney damage before it occurs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote